MSF Statement on KaloBios Plan to Raise Price Of Drug To Treat Chagas Disease
MSF Statement on KaloBios Plan to Raise Price Of Drug To Treat Chagas Disease
December 12, 2015
The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned with the recent announcement that KaloBios has acquired rights to benznidazole, the drug MSF uses to treat Chagas disease in Latin America. KaloBios has announced its intent to register the drug in the United States to obtain a U.S. Federal Drug Administration (FDA) Priority Review Voucher (PRV), and then charge a high price.
Source: MSF News - Category: Global & Universal Authors: Phil Zabriskie Source Type: news
More News: Chagas Disease | International Medicine & Public Health